About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Phase III Trial
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics Signs Development Agreement for TPM Oxymorphone Patch in Japan
August 22, 2017
Click here to read more
Post navigation
Previous Post
Phosphagenics Sells BioElixia Beauty Brand to Pure Beauty Australia
Next Post
June 2017 Half Year Financial Report and Appendix 4D
Related Posts
Ashland Purchases Manufacturing Rights for VitalET and TPM
June 20, 2019
August 28, 2019
Phosphagenics Placement Secures A$1.37 million
January 18, 2018
Avecho licenses TPM® for development of enhanced cancer drugs
May 22, 2023
May 22, 2023